Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation

Paul J. Rozance, Michelle M. Crispo, James S. Barry, Meghan C. O'Meara, Mackenzie S. Frost, Kent C. Hansen, William W. Hay, Laura D. Brown

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Protein supplementation during human pregnancy does not improve fetal growth and may increase small-for-gestational-age birth rates and mortality. To define possible mechanisms, sheep with twin pregnancies were infused with amino acids (AA group, n = 7) or saline (C group, n = 4) for 4 days during late gestation. In the AA group, fetal plasma leucine, isoleucine, valine, and lysine concentrations were increased (P < 0.05), and threonine was decreased (P < 0.05). In the AA group, fetal arterial pH (7.365 ± 0.007 day 0 vs. 7.336 ± 0.012 day 4, P < 0.005), hemoglobin-oxygen saturation (46.2 ± 2.6 vs. 37.8 ± 3.6%, P < 0.005), and total oxygen content (3.17 ± 0.17 vs. 2.49 ± 0.20 mmol/l, P < 0.0001) were decreased on day 4 compared with day 0. Fetal leucine disposal did not change (9.22 ± 0.73 vs. 8.09 ± 0.63 μmol·min -1·kg-1, AA vs. C), but the rate of leucine oxidation increased 43% in the AA group (2.63 ± 0.16 vs. 1.84 ± 0.24 μmol·min-1·kg-1, P < 0.05). Fetal oxygen utilization tended to be increased in the AA group (327 ± 23 vs. 250 ± 29 μmol·min-1·kg-1, P = 0.06). Rates of leucine incorporation into fetal protein (5.19 ± 0.97 vs. 5.47 ± 0.89 μmol·min-1·kg-1, AA vs. C), release from protein breakdown (4.20 ± 0.95 vs. 4.62 ± 0.74 μmol·min-1·kg-1), and protein accretion (1.00 ± 0.30 vs. 0.85 ± 0.25 μmol·min -1·kg-1) did not change. Consistent with these data, there was no change in the fetal skeletal muscle ubiquitin ligases MaFBx1 or MuRF1 or in the protein synthesis regulators 4E-BP1, eEF2, eIF2α, and p70S6K. Decreased concentrations of certain essential amino acids, increased amino acid oxidation, fetal acidosis, and fetal hypoxia are possible mechanisms to explain fetal toxicity during maternal amino acid supplementation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume297
Issue number3
DOIs
StatePublished - Sep 2009

Fingerprint

Leucine
Sheep
Mothers
Amino Acids
Pregnancy
Oxygen
Fetal Hypoxia
Fetal Proteins
70-kDa Ribosomal Protein S6 Kinases
Proteins
Twin Pregnancy
Essential Amino Acids
Isoleucine
Birth Rate
Valine
Threonine
Ligases
Fetal Development
Ubiquitin
Acidosis

Keywords

  • Leucine
  • Metabolism
  • Oxygen
  • Threonine

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation. / Rozance, Paul J.; Crispo, Michelle M.; Barry, James S.; O'Meara, Meghan C.; Frost, Mackenzie S.; Hansen, Kent C.; Hay, William W.; Brown, Laura D.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 297, No. 3, 09.2009.

Research output: Contribution to journalArticle

Rozance, Paul J. ; Crispo, Michelle M. ; Barry, James S. ; O'Meara, Meghan C. ; Frost, Mackenzie S. ; Hansen, Kent C. ; Hay, William W. ; Brown, Laura D. / Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation. In: American Journal of Physiology - Endocrinology and Metabolism. 2009 ; Vol. 297, No. 3.
@article{724182919c434f5b89c8fc862f9de2b4,
title = "Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation",
abstract = "Protein supplementation during human pregnancy does not improve fetal growth and may increase small-for-gestational-age birth rates and mortality. To define possible mechanisms, sheep with twin pregnancies were infused with amino acids (AA group, n = 7) or saline (C group, n = 4) for 4 days during late gestation. In the AA group, fetal plasma leucine, isoleucine, valine, and lysine concentrations were increased (P < 0.05), and threonine was decreased (P < 0.05). In the AA group, fetal arterial pH (7.365 ± 0.007 day 0 vs. 7.336 ± 0.012 day 4, P < 0.005), hemoglobin-oxygen saturation (46.2 ± 2.6 vs. 37.8 ± 3.6{\%}, P < 0.005), and total oxygen content (3.17 ± 0.17 vs. 2.49 ± 0.20 mmol/l, P < 0.0001) were decreased on day 4 compared with day 0. Fetal leucine disposal did not change (9.22 ± 0.73 vs. 8.09 ± 0.63 μmol·min -1·kg-1, AA vs. C), but the rate of leucine oxidation increased 43{\%} in the AA group (2.63 ± 0.16 vs. 1.84 ± 0.24 μmol·min-1·kg-1, P < 0.05). Fetal oxygen utilization tended to be increased in the AA group (327 ± 23 vs. 250 ± 29 μmol·min-1·kg-1, P = 0.06). Rates of leucine incorporation into fetal protein (5.19 ± 0.97 vs. 5.47 ± 0.89 μmol·min-1·kg-1, AA vs. C), release from protein breakdown (4.20 ± 0.95 vs. 4.62 ± 0.74 μmol·min-1·kg-1), and protein accretion (1.00 ± 0.30 vs. 0.85 ± 0.25 μmol·min -1·kg-1) did not change. Consistent with these data, there was no change in the fetal skeletal muscle ubiquitin ligases MaFBx1 or MuRF1 or in the protein synthesis regulators 4E-BP1, eEF2, eIF2α, and p70S6K. Decreased concentrations of certain essential amino acids, increased amino acid oxidation, fetal acidosis, and fetal hypoxia are possible mechanisms to explain fetal toxicity during maternal amino acid supplementation.",
keywords = "Leucine, Metabolism, Oxygen, Threonine",
author = "Rozance, {Paul J.} and Crispo, {Michelle M.} and Barry, {James S.} and O'Meara, {Meghan C.} and Frost, {Mackenzie S.} and Hansen, {Kent C.} and Hay, {William W.} and Brown, {Laura D.}",
year = "2009",
month = "9",
doi = "10.1152/ajpendo.00192.2009",
language = "English (US)",
volume = "297",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation

AU - Rozance, Paul J.

AU - Crispo, Michelle M.

AU - Barry, James S.

AU - O'Meara, Meghan C.

AU - Frost, Mackenzie S.

AU - Hansen, Kent C.

AU - Hay, William W.

AU - Brown, Laura D.

PY - 2009/9

Y1 - 2009/9

N2 - Protein supplementation during human pregnancy does not improve fetal growth and may increase small-for-gestational-age birth rates and mortality. To define possible mechanisms, sheep with twin pregnancies were infused with amino acids (AA group, n = 7) or saline (C group, n = 4) for 4 days during late gestation. In the AA group, fetal plasma leucine, isoleucine, valine, and lysine concentrations were increased (P < 0.05), and threonine was decreased (P < 0.05). In the AA group, fetal arterial pH (7.365 ± 0.007 day 0 vs. 7.336 ± 0.012 day 4, P < 0.005), hemoglobin-oxygen saturation (46.2 ± 2.6 vs. 37.8 ± 3.6%, P < 0.005), and total oxygen content (3.17 ± 0.17 vs. 2.49 ± 0.20 mmol/l, P < 0.0001) were decreased on day 4 compared with day 0. Fetal leucine disposal did not change (9.22 ± 0.73 vs. 8.09 ± 0.63 μmol·min -1·kg-1, AA vs. C), but the rate of leucine oxidation increased 43% in the AA group (2.63 ± 0.16 vs. 1.84 ± 0.24 μmol·min-1·kg-1, P < 0.05). Fetal oxygen utilization tended to be increased in the AA group (327 ± 23 vs. 250 ± 29 μmol·min-1·kg-1, P = 0.06). Rates of leucine incorporation into fetal protein (5.19 ± 0.97 vs. 5.47 ± 0.89 μmol·min-1·kg-1, AA vs. C), release from protein breakdown (4.20 ± 0.95 vs. 4.62 ± 0.74 μmol·min-1·kg-1), and protein accretion (1.00 ± 0.30 vs. 0.85 ± 0.25 μmol·min -1·kg-1) did not change. Consistent with these data, there was no change in the fetal skeletal muscle ubiquitin ligases MaFBx1 or MuRF1 or in the protein synthesis regulators 4E-BP1, eEF2, eIF2α, and p70S6K. Decreased concentrations of certain essential amino acids, increased amino acid oxidation, fetal acidosis, and fetal hypoxia are possible mechanisms to explain fetal toxicity during maternal amino acid supplementation.

AB - Protein supplementation during human pregnancy does not improve fetal growth and may increase small-for-gestational-age birth rates and mortality. To define possible mechanisms, sheep with twin pregnancies were infused with amino acids (AA group, n = 7) or saline (C group, n = 4) for 4 days during late gestation. In the AA group, fetal plasma leucine, isoleucine, valine, and lysine concentrations were increased (P < 0.05), and threonine was decreased (P < 0.05). In the AA group, fetal arterial pH (7.365 ± 0.007 day 0 vs. 7.336 ± 0.012 day 4, P < 0.005), hemoglobin-oxygen saturation (46.2 ± 2.6 vs. 37.8 ± 3.6%, P < 0.005), and total oxygen content (3.17 ± 0.17 vs. 2.49 ± 0.20 mmol/l, P < 0.0001) were decreased on day 4 compared with day 0. Fetal leucine disposal did not change (9.22 ± 0.73 vs. 8.09 ± 0.63 μmol·min -1·kg-1, AA vs. C), but the rate of leucine oxidation increased 43% in the AA group (2.63 ± 0.16 vs. 1.84 ± 0.24 μmol·min-1·kg-1, P < 0.05). Fetal oxygen utilization tended to be increased in the AA group (327 ± 23 vs. 250 ± 29 μmol·min-1·kg-1, P = 0.06). Rates of leucine incorporation into fetal protein (5.19 ± 0.97 vs. 5.47 ± 0.89 μmol·min-1·kg-1, AA vs. C), release from protein breakdown (4.20 ± 0.95 vs. 4.62 ± 0.74 μmol·min-1·kg-1), and protein accretion (1.00 ± 0.30 vs. 0.85 ± 0.25 μmol·min -1·kg-1) did not change. Consistent with these data, there was no change in the fetal skeletal muscle ubiquitin ligases MaFBx1 or MuRF1 or in the protein synthesis regulators 4E-BP1, eEF2, eIF2α, and p70S6K. Decreased concentrations of certain essential amino acids, increased amino acid oxidation, fetal acidosis, and fetal hypoxia are possible mechanisms to explain fetal toxicity during maternal amino acid supplementation.

KW - Leucine

KW - Metabolism

KW - Oxygen

KW - Threonine

UR - http://www.scopus.com/inward/record.url?scp=69049092136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049092136&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00192.2009

DO - 10.1152/ajpendo.00192.2009

M3 - Article

VL - 297

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -